Genetic testing in aortic aneurysm disease: PRO

Cardiology Clinics

Volumn 28, Issue 2, 2010, Pages 191-197

  Milewicz, Dianna M ^a   Carlson, Alicia A ^a   Regalado, Ellen S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ACTA2; Familial thoracic aortic aneurysm and dissection; FBN1; Loeys Dietz syndrome; Marfan syndrome; MYH11; TGFBR1; TGFBR2

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MYOSIN HEAVY CHAIN BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

AORTA ANEURYSM; AORTA DISEASE; AORTA DISSECTION; AUTOSOMAL DOMINANT INHERITANCE; FAMILIAL DISEASE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; MARFAN SYNDROME; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THORACIC AORTA ANEURYSM; AORTIC ANEURYSM; GENETICS; PROCEDURES; REPRODUCIBILITY;

AORTIC ANEURYSM; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 77952625340     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2010.01.017     Document Type: Review

References (39)

1. Milewicz D.M., Dietz H.C., Miller D.C. Treatment of aortic disease in patients with Marfan syndrome. Circulation 2005, 111:e150-e157.
2. Finkbohner R., Johnston D., Crawford E.S., et al. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 1995, 91:728-733.
3. Silverman D.I., Gray J., Roman M.J., et al. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol 1995, 26:1062-1067.
4. Silverman D.I., Burton K.J., Gray J., et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995, 75:157-160.
5. van Karnebeek C.D., Naeff M.S., Mulder B.J., et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001, 84:129-137.
6. Milewicz D.M., Grossfield J., Cao S.N., et al. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 1995, 95:2373-2378.
7. Milewicz D.M., Michael K., Fisher N., et al. Fibrillin-1 FBN1 mutations in patients with thoracic aortic aneurysms. Circulation 1996, 94:2708-2711.
8. Francke U., Berg M.A., Tynan K., et al. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic-aneurysm and dissection. Am J Hum Genet 1995, 56:1287-1296.
9. Ades L.C., Sreetharan D., Onikul E., et al. Segregation of a novel FBN1 gene mutation, G1796E, with kyphoscoliosis and radiographic evidence of vertebral dysplasia in three generations. Am J Med Genet 2002, 109:261-270.
10. Katzke S., Booms P., Tiecke F., et al. TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies. Hum Mutat 2002, 20:197-208.
11. Stheneur C., Collod-Beroud G., Faivre L., et al. Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene. Eur J Hum Genet 2009, 17:1121-1128.
12. Loeys B., De Backer J., Van Acker P., et al. Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome. Hum Mutat 2004, 24:140-146.
13. Boileau C., Jondeau G., Babron M.C., et al. Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet 1993, 53:46-54. [see comments].
14. Collod G., Babron M.C., Jondeau G., et al. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet 1994, 8:264-268. [see comments].
15. Dietz H., Francke U., Furthmayr H., et al. The question of heterogeneity in Marfan syndrome. Nat Genet 1995, 9:228-231.
16. Loeys B.L., Schwarze U., Holm T., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006, 355:788-798.
17. LeMaire S.A., Pannu H., Tran-Fadulu V., et al. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nat Clin Pract Cardiovasc Med 2007, 4:167-171.
18. Williams J.A., Loeys B.L., Nwakanma L.U., et al. Early surgical experience with Loeys-Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease. Ann Thorac Surg 2007, 83:S757-S763.
19. Loeys B.L., Chen J., Neptune E.R., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005, 37:275-281.
20. Nicod P., Bloor C., Godfrey M., et al. Familial aortic dissecting aneurysm. J Am Coll Cardiol 1989, 13:811-819.
21. Biddinger A., Rocklin M., Coselli J., et al. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 1997, 25:506-511.
22. Coady M.A., Davies R.R., Roberts M., et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999, 134:361-367.
23. Albornoz G., Coady M.A., Roberts M., et al. Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006, 82:1400-1405.
24. Milewicz D.M., Chen H., Park E.S., et al. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol 1998, 82:474-479.
25. McKusick V.A. Association of congenital bicuspid aortic valve and erdheim's cystic medial necrosis. Lancet 1972, 1:1026-1027.
26. Glick B.N., Roberts W.C. Congenitally bicuspid aortic valve in multiple family members. Am J Cardiol 1994, 73:400-404.
27. Clementi M., Notari L., Borghi A., et al. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance. Am J Med Genet 1996, 62:336-338.
28. Loscalzo M.L., Goh D.L., Loeys B., et al. Familial thoracic aortic dilation and bicommissural aortic valve: a prospective analysis of natural history and inheritance. Am J Med Genet A 2007, 143:1960-1967.
29. Glancy D.L., Wegmann M., Dhurandhar R.W. Aortic dissection and patent ductus arteriosus in three generations. Am J Cardiol 2001, 87:813-815. A9.
30. Khau Van K.P., Wolf J.E., Mathieu F., et al. Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. Eur J Hum Genet 2004, 12:173-180.
31. Pannu H., Fadulu V., Chang J., et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005, 112:513-520.
32. Zhu L., Vranckx R., Khau Van K.P., et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 2006, 38:343-349.
33. Guo D.C., Pannu H., Papke C.L., et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007, 39:1488-1493.
34. Law C., Bunyan D., Castle B., et al. Clinical features in a family with an R460H mutation in transforming growth factor beta receptor 2 gene. J Med Genet 2006, 43:908-916.
35. Tran-Fadulu V.T., Pannu H., Kim D.H., et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009, 46:607-613.
36. Van Kien P.K., Mathieu F., Zhu L., et al. Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation 2005, 112:200-206.
37. Pannu H., Tran-Fadulu V., Papke C.L., et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 2007, 16:3453-3462.
38. Fatigati V., Murphy R.A. Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. J Biol Chem 1984, 259:14383-14388.
39. Guo D.C., Papke C.L., Tran-Fadulu V., et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009, 84:617-627.